Merrill Lynch downgrades Cross Country Healthcare (Nasdaq: CCRN) from Buy to Underperform.
This article: 57 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE